Login
Toggle sidebar

Lint: primary-biliary-cholangitis

primary-biliary-cholangitis
Strong
warning

"The name of this disease was changed from primary biliary cirrhosis to primary biliary cholangitis in 2014, keeping the acronym PBC 9."

Line 3:46 · Generally, don't use bold in text: '<strong>primary biliary cirrhosis</strong>'

"The name of this disease was changed from primary biliary cirrhosis to primary biliary cholangitis in 2014, keeping the acronym PBC 9."

Line 3:92 · Generally, don't use bold in text: '<strong>primary biliary cholangitis </strong>'
Acronyms
warning

"PBC should be suspected in patients, in particular middle-aged females, with cholestasis and raised ALP with no other cause identified, with AMA positivity confirming the diagnosis 10,11. Liver biopsy is usually not indicated, but may be considered in patients with suspected AMA-negative PBC 10,11."

Line 7:104 · 'ALP' has no definition. Spell it out if it's unfamiliar to the audience.

"PBC should be suspected in patients, in particular middle-aged females, with cholestasis and raised ALP with no other cause identified, with AMA positivity confirming the diagnosis 10,11. Liver biopsy is usually not indicated, but may be considered in patients with suspected AMA-negative PBC 10,11."

Line 7:145 · 'AMA' has no definition. Spell it out if it's unfamiliar to the audience.

"PBC should be suspected in patients, in particular middle-aged females, with cholestasis and raised ALP with no other cause identified, with AMA positivity confirming the diagnosis 10,11. Liver biopsy is usually not indicated, but may be considered in patients with suspected AMA-negative PBC 10,11."

Line 7:291 · 'AMA' has no definition. Spell it out if it's unfamiliar to the audience.

"liver function tests are elevated, in particular, ALP 10"

Line 31:58 · 'ALP' has no definition. Spell it out if it's unfamiliar to the audience.
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Associations"

Line 12:1 · "Associations" is under the wrong parent heading (found under "Pathology").

"CT / MRI"

Line 51:1 · "CT / MRI" is not a recognised heading for this article type.

"Complications"

Line 87:1 · "Complications" is under the wrong parent heading (found under "Treatment and prognosis").
Commas
suggestion

"additional risk in older patients, males, presence of cirrhosis, history of diabetes mellitus, or past hepatitis B virus infection 6,15,16"

Line 24:45 · More than 5 commas in a single sentence might make it more difficult to read.
Semicolons
suggestion

"hepatomegaly (~30% of cases; range 11-50%) 20"

Line 57:42 · Use semicolons judiciously.

"typically, PBC affects small intrahepatic bile ducts ("

Line 72:143 · Use semicolons judiciously.

"common feature in PBC (~75%; range 62-88%), and more in other aetiologies of chronic liver disease 3,20"

Line 77:35 · Use semicolons judiciously.
Links
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0